Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Combination of sEphB4-HSA and pembrolizumab shows promise in HPV-negative EphrinB2 positive HNSCC

Combination of sEphB4-HSA and pembrolizumab shows promise in HPV-negative EphrinB2 positive HNSCC

Women with endometriosis have a significantly increased ovarian cancer risk, study finds

Women with endometriosis have a significantly increased ovarian cancer risk, study finds

Research highlights green tea's potential role in improving ovarian cancer outcomes

Research highlights green tea's potential role in improving ovarian cancer outcomes

Distinct signaling pathway drives the transformation of epithelial cells into aggressive tumors

Distinct signaling pathway drives the transformation of epithelial cells into aggressive tumors

Navigating adjuvant therapy options in hepatocellular carcinoma

Navigating adjuvant therapy options in hepatocellular carcinoma

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Antibody-drug conjugate shows preclinical efficacy

Antibody-drug conjugate shows preclinical efficacy

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

GLP-1 drugs found to lower cancer risk in diabetes patients

GLP-1 drugs found to lower cancer risk in diabetes patients

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Algorithm assists doctors in identifying highly aggressive form of basal cell carcinoma of the face

Algorithm assists doctors in identifying highly aggressive form of basal cell carcinoma of the face

Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

PFDN6 protein could be a new target for colorectal cancer treatment

PFDN6 protein could be a new target for colorectal cancer treatment

Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers

Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers

Study finds lower cancer risk with alcohol abstinence and rehabilitation

Study finds lower cancer risk with alcohol abstinence and rehabilitation

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.